New England Journal of Medicine: Volume 394, Issue 15 (April 16, 2026)
This week’s Latest England Journal of Medicine reports that a novel oral antiviral compound, Virostat-7, reduced hospitalization rates by 42% in immunocompromised adults with persistent SARS-CoV-2 infection when administered within ... Read More